Magnesium Lithospermate B Suppresses the Increase of Active Oxygen in Rats after Subtotal Nephrectomy

Nephron

Volumn 75, Issue 1, 1997, Pages 88-93

  Yokozawa, Takako ^a   Dong, Erbo ^a   Oura, Hikokichi ^a   Kashiwagi, Hiroshi ^a   Nonaka, Gen Ichiro ^a   Nishioka, Itsuo ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Active oxygen; Magnesium lithospermate B; Nephrectomy; Rat; Spin trapping

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; CATALASE; HYDROXYL RADICAL; MAGNESIUM LITHOSPERMATE; SUPEROXIDE DISMUTASE; UREMIC TOXIN;

ANIMAL EXPERIMENT; ARTICLE; KIDNEY FAILURE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RAT; SPIN TRAPPING;

EID: 0031037488     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189505     Document Type: Article

References (30)

1. Hostettcr TH, Olson JL, Rennkc HG. Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981: 241: F85-F93.
2. Olson JL. Hostettcr TH. Rennke HG. Brenner BM. Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Im 1982:22:112-126.
3. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
4. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983;23:647-655.
5. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol I985:249:F324-F337.
6. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985:76:612-619.
7. Anderson S. Rennkc HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
8. Schrier RW, Harris DCH, Chan L. Shapiro JI. Caramelo C: Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am J Kidney Dis 1988; 12:243-249.
9. Harris DCH. Chan L. Schrier RW: Remnant kidney hypermetabolism and progression of chronic renal failure. Am J Physiol 1988:254: F267-F276.
10. Sanaka T. Higuchi C. Omata M: Active oxygen as the progressive factor of chronic renal failure. Ren Fail 1991:3:73-77.
11. Yokozawa T. Zhou JJ. Hattori M, Inaba S, Okada T. Oura H. Nonaka G. Nishioka I: Effects of a Dan Shen component, magnesium lithospermate B. in nephrectomizcd rats. Jpn J Nephrol 1995:37:105-111.
12. Platt R. Roscoe MH. Smith FW: Experimental renal failure. Clin Sei 1952:11:217-231.
13. Morrison AB: Experimental chronic renal insufficiency. Methods Achicv Exp Pathol 1966; 1:455-475.
14. Yokozawa T, Chung HY. Oura H. Nonaka G. Nishioka I: Isolation of a renal function-facilitating constituent from the Oriental drug, Sal-viae Miltiorrhizae Radix. Jpn J Nephrol 1989; 31:1091-1098.
15. Yokozawa T. Lee TW, Oura H, Nonaka G. Nishioka I: Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 1992;60:460-465.
16. Elstner EF. Heupel A: Inhibition of nitrile formation from hydroxyl-ammomumchloride: A simple assay for superoxide dismutase. Anal Biochem 1976;70:616-620.
17. Oyanagui Y: Réévaluation of assay methods and establishment of kit for Superoxide dismutase activity. Anal Biochem 1984:142:290-296.
18. Aebi H: Catalase; in Bergmcycr HU (ed): Methods of Enzymatic Analysis. New York, Verlag Chemie. 1974. pp 673-684.
19. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
20. Lowry OH. Rosebrough NJ, Farr AL. Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951:193:265-275.
21. Fujita Y: Radicals observed in the rat brain mitochondria by spin trapping method; in Kondo M, Oyanagui Y, Yoshikawa T (eds): Free Radicals in Clinical Biology. Tokyo. Nihon-Igakukan, 1987, vol 2, pp 39-49.
22. Yokozawa T. Fujitsuka N. Oura H. Mori A, Kashiwagi H: Determination of radical species in the kidney of rats with chronic renal failure by the spin trapping method. Nephron 1995; 70:382-384.
23. Higashidate S. Mackubo T. Saito M, Scnda M. Hoshino T: Rapid and highly sensitive method for the determination of guanidino compounds in bodv fluids. Bunseki Kagaku 1984:33:366-370.
24. Mori A. Hiramatsu M: Determination of hy-droperoxy radical and hydroxyl radical using electron spin resonance and its application: in Ogita Z. Oura H (eds): Active Oxygen. Tokyo. Kyoritsu Shuppan, 1987, pp 114-129.
25. Marklund S: Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol Scand Suppl 1980:492:19-23.
26. Agar NS. Sadrzadeh SMH. Hallaway PE. Eaton JW: Erythrocyte catalase. J Clin Invest 1986;77:319-321.
27. Winterboum CC, Stern A: Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J Clin Invest 1987;80:1486-1491.
28. Yoshikawa T. Naito Y, Yasuda M, Kondo M: The changes of anlioxidativc enzymes in diseases. J Act OxygFree Rad 1991:2:81-91.
29. Watabe T. Hiralsuka A: Glutathione peroxidases. Protein Nucleic Acid Enzyme 1988:33: 2949-2956.
30. Yokozawa T. Oura H, Iwano M. Dohi K, Hat-tori M: Inhibitory effects of crude drug components on the proliferation of cultured human mesangial cells. Jpn J Nephrol 1993:35:321-327.